{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T15:37:03Z","timestamp":1758814623948},"reference-count":12,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[1990,5,1]],"date-time":"1990-05-01T00:00:00Z","timestamp":641520000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,6,28]]},"abstract":"<jats:title>SUMMARY<\/jats:title>\n               <jats:p>This study was undertaken to define the risk of AIDS in a cohort of 250 HIV-seropositivc patients identified by their clinical and biological status. All patients were enrolled between October 1985 and March 1988. They were classified according to clinical classes A, asymptomatic (n= 97); B. lymphadenopathic(n= 123); and C, AIDS-related complex, (n= 30). Also as CD4 cell stages 1 (CD4 \u00b1 600\/\u03bcl;n= 126); 2(CD4 &amp;lt; 600 and \u00b1 300\/\u03bc1; n= 83); and 3 (CD4 &amp;lt; 300\/\u03bcl; n= 41); and serum p24 antigen positive (n= 48) or negative (n= 202). All patients were evaluated every 3\u20136 months, until AIDS development or April 1989: 29 cases of AIDS occurred during the follow-up period. The risk of AIDS in class C is very high (64% at 2 years) compared with the 3-year risk of classes A (13%) and B (25%). On the other hand the three CD4 stages have significantly different prognosis (stage 1 6%; stage 2 22%; and stage 3 89%; P &amp;lt; 10\u22122). Antigen p24 negative and positive patients have also different prognosis (18% and 53%; P &amp;lt; 10\u22124). Interestingly. p24 antigen conserved its prognostic value in stage 2 (positive 37%. negative 16%) while stages I are at low risk of AIDS and stages 3 at high risk whatever their p24 antigen status. We have also identified the risk of becoming stage 3 and\/or p24 antigen positive in p24 antigen negative patients at stages 1 and 2 (respectively, 18% and 47%). This classification should serve to design randomized trials better with experimental drugs with earlier end-points than AIDS onset.<\/jats:p>","DOI":"10.1111\/j.1365-2249.1990.tb05224.x","type":"journal-article","created":{"date-parts":[[2010,7,26]],"date-time":"2010-07-26T17:23:44Z","timestamp":1280165024000},"page":"151-155","source":"Crossref","is-referenced-by-count":6,"title":["Actuarial rate of clinical and biological progression in a cohort of 250 HIV-1-seropositive subjects"],"prefix":"10.1093","volume":"80","author":[{"given":"A","family":"VENET","sequence":"first","affiliation":[{"name":"Laennec HIV Study Group, Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J-M","family":"TOURANI","sequence":"additional","affiliation":[{"name":"Laennec HIV Study Group, Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"BELDJORD","sequence":"additional","affiliation":[{"name":"Laennec HIV Study Group, Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"EME","sequence":"additional","affiliation":[{"name":"Laennec HIV Study Group, Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"EVEN","sequence":"additional","affiliation":[{"name":"Laennec HIV Study Group, Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J-M","family":"ANDRIEU","sequence":"additional","affiliation":[{"name":"Laennec HIV Study Group, Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2008,6,28]]},"reference":[{"key":"2022011713423524200_b1","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1056\/NEJM198710293171804","article-title":"Long-term evaluation of HIV antigen and antibodies to p24 and gp4l in patients with hemophilia. Potential clinical importance","volume":"317","author":"Allain","year":"1987","journal-title":"N. Engl. J. Med"},{"key":"2022011713423524200_b2","first-page":"I","article-title":"Serum HIV antigen and anti-p24 antibodies in 200 HIV seropositive patients: correlation with CD4 and CDS lymphocyte subsets","volume":"73","author":"Andrieu","year":"1988","journal-title":"Clin. exp. Immunol"},{"key":"2022011713423524200_b3","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/338251a0","article-title":"Incubation period of AIDS in San Francisco","volume":"338","author":"Bacchetti","year":"1989","journal-title":"Nature"},{"key":"2022011713423524200_b4","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1093\/infdis\/156.5.830","article-title":"Human immunodeficiency virus antigenemia in patients with AIDS and AIDS-related disorders: a comparison between European and Central African populations","volume":"156","author":"Baillou","year":"1987","journal-title":"J. infect. Dis"},{"key":"2022011713423524200_b5","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1093\/infdis\/158.3.615","article-title":"Numbers of CD4+ cells and the levels of core antigens of and antibodies to the human immunodeficiency virus as predictors of AIDS among seropositive homosexual men","volume":"158","author":"De Wolf","year":"1988","journal-title":"J. infect. Dis"},{"key":"2022011713423524200_b6","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/S0140-6736(88)92903-0","article-title":"Effects of zidovudine in 365 consecutive patients with AIDS or AIDS related complex","volume":"ii","author":"Dournon","year":"1988","journal-title":"Lancet"},{"key":"2022011713423524200_b7","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1001\/jama.1987.03390030061021","article-title":"Effect of T4 count and cofactors on the incidence of AIDS in homosexual men infected with human immunodeficiency virus","volume":"257","author":"Goedert","year":"1987","journal-title":"JAMA"},{"key":"2022011713423524200_b8","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1136\/bmj.293.6560.1459","article-title":"Persistent HIV antigenemia and decline of HIV core antibodies associated with transition to AIDS","volume":"293","author":"Lange","year":"1986","journal-title":"Br. med. J"},{"key":"2022011713423524200_b9","first-page":"367","article-title":"Prognostic usefulness of the Walter Reed staging classification for HIV infection","volume":"1","author":"McDonell","year":"1988","journal-title":"J. AIDS"},{"key":"2022011713423524200_b10","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/00002030-198902000-00001","article-title":"Natural history of HIV infection","volume":"3","author":"Moss","year":"1989","journal-title":"AIDS"},{"key":"2022011713423524200_b11","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1136\/bmj.296.6624.745","article-title":"Seropositivity for HIV and the development of AIDS or AIDS related condition: three years follow up of the San Francisco General Hospital cohort","volume":"296","author":"Moss","year":"1988","journal-title":"Br. med. J"},{"key":"2022011713423524200_b12","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1056\/NEJM198701083160201","article-title":"Predictors of the acquired immunodeficiency syndrome developing in a cohort of seropositive homosexual men","volume":"316","author":"Polk","year":"1987","journal-title":"N. Engl. J. Med"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2249.1990.tb05224.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/80\/2\/151\/42218272\/j.1365-2249.1990.tb05224.x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/80\/2\/151\/42218272\/j.1365-2249.1990.tb05224.x.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,17]],"date-time":"2022-01-17T13:44:06Z","timestamp":1642427046000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/80\/2\/151\/6490444"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1990,5]]},"references-count":12,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2008,6,28]]},"published-print":{"date-parts":[[2008,6,28]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2249.1990.tb05224.x","relation":{},"ISSN":["1365-2249","0009-9104"],"issn-type":[{"value":"1365-2249","type":"electronic"},{"value":"0009-9104","type":"print"}],"subject":[],"published-other":{"date-parts":[[1990,5]]},"published":{"date-parts":[[1990,5]]}}}